Attendees will review a spontaneous case report for a fictitious marketed product to determine seriousness, expectedness and regulatory reporting requirements.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 18: Spontaneous Case Report

Session Chair(s)

Jill W. Buckley, PharmD

Be informed and stay engaged.